Osaic Holdings
CGEM icon

Osaic Holdings’s Cullinan Oncology CGEM Stock Holding History

Osaic Holdings’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3K Buy
1,390
+1,006
+262% +$14.9K ﹤0.01% 5984
2026
Q1 		$5.46K Buy
384
+141
+58% +$1.81K ﹤0.01% 6644
2025
Q4 		$2.52K Buy
+243
New +$2.19K ﹤0.01% 7004
2025
Q3 		– Sell
-2,115
Closed -$15.9K – 7910
2025
Q2 		$15.9K Buy
+2,115
New +$17K ﹤0.01% 5872
2025
Q1 		– Sell
-110
Closed -$1.34K – 7479
2024
Q4 		$1.34K Buy
+110
New +$1.58K ﹤0.01% 6747
2024
Q3 		– Sell
-50
Closed -$872 – 7418
2024
Q2 		$872 Buy
+50
New +$1.06K ﹤0.01% 6853

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Osaic Holdings's CGEM Position: Q2 2026 in Review

Osaic Holdings increased its Cullinan Oncology (CGEM) stake by 262% in Q2 2026, buying an estimated $14.9K and bringing the position to 1,390 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5984.

Osaic Holdings first reported a position in CGEM in Q2 2024 and has held it in 6 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Osaic Holdings held 1,390 shares of Cullinan Oncology worth $25.3K as of Q2 2026.
  • Osaic Holdings bought 1,006 Cullinan Oncology shares in Q2 2026, an estimated $14.9K.
  • Cullinan Oncology made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5984 holding.
  • Osaic Holdings first reported a position in Cullinan Oncology in Q2 2024 and has held it in 6 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.